Corcept Therapeutics (CORT) Shares Outstanding (2016 - 2022)
Historic Shares Outstanding for Corcept Therapeutics (CORT) over the last 9 years, with Q4 2022 value amounting to $107.8 million.
- Corcept Therapeutics' Shares Outstanding rose 178.87% to $107.8 million in Q4 2022 from the same period last year, while for Dec 2022 it was $107.8 million, marking a year-over-year increase of 178.87%. This contributed to the annual value of $107.8 million for FY2022, which is 178.87% up from last year.
- As of Q4 2022, Corcept Therapeutics' Shares Outstanding stood at $107.8 million, which was up 178.87% from $107.6 million recorded in Q3 2022.
- In the past 5 years, Corcept Therapeutics' Shares Outstanding ranged from a high of $116.7 million in Q4 2020 and a low of $105.9 million during Q4 2021
- Over the past 5 years, Corcept Therapeutics' median Shares Outstanding value was $115.0 million (recorded in 2018), while the average stood at $113.2 million.
- Its Shares Outstanding has fluctuated over the past 5 years, first surged by 190.84% in 2020, then plummeted by 924.74% in 2021.
- Over the past 5 years, Corcept Therapeutics' Shares Outstanding (Quarter) stood at $115.0 million in 2018, then dropped by 0.42% to $114.5 million in 2019, then rose by 1.91% to $116.7 million in 2020, then decreased by 9.25% to $105.9 million in 2021, then rose by 1.79% to $107.8 million in 2022.
- Its Shares Outstanding stands at $107.8 million for Q4 2022, versus $107.6 million for Q3 2022 and $106.7 million for Q2 2022.